|Bid||147.19 x 2200|
|Ask||159.66 x 2200|
|Day's Range||154.37 - 154.98|
|52 Week Range||120.75 - 155.44|
|PE Ratio (TTM)||N/A|
|Expense Ratio (net)||0.07%|
Hopes for Trump's tax reforms, abating North Korea fears, lower-than-expected damage from Hurricane Irma and record stock market highs rekindled the love for U.S. equity ETFs last week.
Small-capitalization stock investors were defensive going into the 2017, but they have quickly changed their tune, turning to more growth-weighted smaller company picks. Investors can also gain diversified ...
Acadia Pharmaceuticals (ACAD) plans to focus on long-term care (or LTC) facilities to boost Nuplazid’s adoption in the Parkinson’s disease (or PD) psychosis indication.
In 1Q17, Bioverativ’s Eloctate witnessed revenues close to $155.9 million, which is about $48.0 million more YoY (year-over-year).
Abiomed (ABMD) reported a ~100% reorder rate in fiscal 4Q17, amounting to around $103.3 million, which was 34% higher on a YoY basis.
In 1Q17, Align Technology (ALGN) witnessed an 11.4% sequential rise in the volume of Invisalign cases used by doctors in international markets.
As the market tries to digest the surprising UK election results and Thursday’s testimony by ex FBI chief James Comey there is one market sector that is starting to emerge as a new leader. Many Wall Street pros are either not bullish on the small cap stocks or are negative but why?
Zacks Value Investor Highlights: Vanguard Small Cap Value ETF, Vanguard Small-Cap Growth ETF, CAI International, Energy Recovery and Rocky Brands
Exelixis is now developing a strong sales team to support the commercial launch of Cabometyx for indications like first-line RCC and second-line HCC.
The global markets approval of the French election results was clear at 6:30 PM on Sunday as the S&P 500 E-Mini futures gapped 20 points higher when they opened. By early Monday the Euro zone markets ...
The concerns over earnings season, the French election and the prospect of another broken promise will weigh on stocks this week but the bullish evidence continues to build .....
By Bruce Aronow , James MacGregor , Shri Singhvi , Samantha S. Lau April 10, 2017 Though the “Trump bump” helped, the year-old winning streak in smaller stocks owes far more to the spirited US economy. This rally has firepower, but we’d be choosy in ...
Baron Capital began investing in Vail Resorts in 1997, and it owns a ~15%–20% stake in the company. According to Ron Baron, this investment has returned ~50%–75%.
Last week's strong stock performance and bullish market internals were consistent with the resumption of the post-election rally. The stock market's narrow range and the failure to exceed the January highs had put many investors as well as traders on the sidelines. So what should you do?